Apo-Care Pharma

Apo-care Pharma is a German specialty pharmaceutical company headquartered in Bielefeld, specializing in the development and distribution of high-quality oncology, palliative care, and ophthalmology products. Founded in 2004, the company established a strong reputation for providing cost-effective therapeutic options and specialized clinical supplies for complex chronic conditions. In May 2019, Apo-care Pharma was acquired by STADA Arzneimittel AG, a move that significantly expanded STADA's portfolio in the specialty pharmaceuticals and oncology sectors. Today, the company operates as a key subsidiary within the STADA Group, leveraging an extensive distribution network to deliver essential medications to hospitals and pharmacies across Europe. Its portfolio includes a variety of injectable and oral formulations tailored for intensive medical care and pain management.